HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $612,000 | -8.9% | 5,326 | 0.0% | 0.05% | -13.6% |
Q3 2019 | $672,000 | -3.2% | 5,326 | -7.6% | 0.06% | -9.2% |
Q2 2019 | $694,000 | +37.7% | 5,763 | 0.0% | 0.06% | +38.3% |
Q1 2019 | $504,000 | -56.6% | 5,763 | -50.4% | 0.05% | -57.7% |
Q4 2018 | $1,162,000 | +57.2% | 11,610 | +80.0% | 0.11% | +85.0% |
Q3 2018 | $739,000 | +202.9% | 6,451 | +136.8% | 0.06% | +160.9% |
Q2 2018 | $244,000 | – | 2,724 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |